Cost-Effectiveness of Pembrolizumab for Unresectable Metastatic Melanoma After Progression with Ipilimumab in England
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1150
https://www.valueinhealthjournal.com/article/S1098-3015(15)03226-X/fulltext
Title :
Cost-Effectiveness of Pembrolizumab for Unresectable Metastatic Melanoma After Progression with Ipilimumab in England
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03226-X&doi=10.1016/j.jval.2015.09.1150
First page :
A453
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
652